Your browser doesn't support javascript.
loading
A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma.
Kim, Min Kyoung; Kim, Kihyun; Min, Chang-Ki; Kwak, Jae-Yong; Bae, Sang-Byung; Yoon, Sung-Soo; Lee, Je-Jung; Kim, Ki Hwan; Nam, Seung-Hyun; Mun, Yeung-Chul; Kim, Hyo Jung; Bae, Sung Hwa; Shin, Ho-Jin; Lee, Jung-Hee; Park, Joon Seong; Jeong, Seong Hyun; Lee, Mark Hong; Kim, Yang-Soo; Lee, Ho Sup; Park, Keon Woo; Lee, Won-Sik; Lee, Sang Min; Lee, Jeong-Ok; Hyun, Myung Soo; Jo, Deog Yeon; Lim, Sung-Nam; Lee, Jae Hoon; Cho, Do-Yeun; Do, Young Rok; Kim, Jeong-A; Park, Seong Kyu; Kim, Jin Seok; Kim, Soo-Jeong; Kim, Hawk; Yi, Hyeon Gyu; Moon, Joon Ho; Choi, Chul Won; Kim, Sung-Hyun; Joo, Young-Don; Kim, Hoon-Gu; Kim, Byung Soo; Park, Moo-Rim; Song, Moo-Kon; Kim, Su-Youn.
Afiliação
  • Kim MK; Department of Medicine, Yeungnam University College of Medicine, Daegu, Korea.
  • Kim K; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Min CK; Division of Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Kwak JY; Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea.
  • Bae SB; Department of Internal Medicine, Soonchunhyang University Hospital, Cheonan, Korea.
  • Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Lee JJ; Department of Hematology/Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Kim KH; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
  • Nam SH; Department of Internal Medicine, VHS Medical Center, Seoul, Korea.
  • Mun YC; Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
  • Kim HJ; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
  • Bae SH; Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea.
  • Shin HJ; Department of Internal Medicine, Division of Hematology/Oncology, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea.
  • Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Park JS; Department of Hematology/Oncology, Ajou University School of Medicine, Suwon, Korea.
  • Jeong SH; Department of Hematology/Oncology, Ajou University School of Medicine, Suwon, Korea.
  • Lee MH; Department of Internal Medicine, Konkuk University Medical Center, Seoul, Korea.
  • Kim YS; Department of Hematology/Oncology, Kosin University College of Medicine, Busan, Korea.
  • Lee HS; Department of Hematology/Oncology, Kosin University College of Medicine, Busan, Korea.
  • Park KW; Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
  • Lee WS; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.
  • Lee SM; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.
  • Lee JO; Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.
  • Hyun MS; Department of Medicine, Yeungnam University College of Medicine, Daegu, Korea.
  • Jo DY; Department of Hematology/Oncology, Chungnam National University Hospital, Daejeon, Korea.
  • Lim SN; Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Lee JH; Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
  • Cho DY; Department of Internal Medicine, Konyang University Hospital, Daejeon, Korea.
  • Do YR; Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
  • Kim JA; Department of Hematology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Park SK; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
  • Kim JS; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Kim SJ; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Kim H; Division of Hematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Yi HG; Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, Korea.
  • Moon JH; Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea.
  • Choi CW; Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • Kim SH; Department of Internal Medicine, Dong-A Medical Center, Dong-A University College of Medicine, Busan, Korea.
  • Joo YD; Department of Hemato-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea.
  • Kim HG; Department of Internal Medicine, Gyeongsang Institute of Health Sciences, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Korea.
  • Kim BS; Department of Hematology, Korea University Medical Center, Korea University College of Medicine, Seoul, Korea.
  • Park MR; Department of Internal Medicine, School of Medicine, Wonkwang University, Iksan, Korea.
  • Song MK; Department of Hemato-Oncology, Hanyang University Hanmaeum Changwon Hospital, Changwon, Korea.
  • Kim SY; Medical Affairs, Janssen Korea, Seoul, Korea.
Oncotarget ; 8(23): 37605-37618, 2017 Jun 06.
Article em En | MEDLINE | ID: mdl-28402945
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos